PubMed:2788166 / 113-272 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T2","span":{"begin":0,"end":159},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":159},"obj":"Sentence"}],"text":"Alpha 1-Antitrypsin (alpha 1AT) deficiency is characterized by reduced serum levels of alpha 1AT and a risk for the development of emphysema and liver disease."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":0,"end":159},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":159},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Alpha 1-Antitrypsin (alpha 1AT) deficiency is characterized by reduced serum levels of alpha 1AT and a risk for the development of emphysema and liver disease."}

{"project":"Glycosmos6-MAT","denotations":[{"id":"T3","span":{"begin":145,"end":150},"obj":"http://purl.obolibrary.org/obo/MAT_0000097"}],"text":"Alpha 1-Antitrypsin (alpha 1AT) deficiency is characterized by reduced serum levels of alpha 1AT and a risk for the development of emphysema and liver disease."}

{"project":"DisGeNET","denotations":[{"id":"T0","span":{"begin":0,"end":19},"obj":"gene:5265"},{"id":"T1","span":{"begin":131,"end":140},"obj":"disease:C0034067"},{"id":"T2","span":{"begin":0,"end":19},"obj":"gene:5265"},{"id":"T3","span":{"begin":145,"end":158},"obj":"disease:C0023895"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T0","obj":"T1"},{"id":"R2","pred":"associated_with","subj":"T2","obj":"T3"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Alpha 1-Antitrypsin (alpha 1AT) deficiency is characterized by reduced serum levels of alpha 1AT and a risk for the development of emphysema and liver disease."}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":131,"end":140},"obj":"HP_0002097"}],"text":"Alpha 1-Antitrypsin (alpha 1AT) deficiency is characterized by reduced serum levels of alpha 1AT and a risk for the development of emphysema and liver disease."}

{"project":"DisGeNET5_gene_disease","denotations":[{"id":"2788166-1#0#19#gene5265","span":{"begin":0,"end":19},"obj":"gene5265"},{"id":"2788166-1#131#140#diseaseC0034067","span":{"begin":131,"end":140},"obj":"diseaseC0034067"},{"id":"2788166-1#145#158#diseaseC0023895","span":{"begin":145,"end":158},"obj":"diseaseC0023895"}],"relations":[{"id":"0#19#gene5265131#140#diseaseC0034067","pred":"associated_with","subj":"2788166-1#0#19#gene5265","obj":"2788166-1#131#140#diseaseC0034067"},{"id":"0#19#gene5265145#158#diseaseC0023895","pred":"associated_with","subj":"2788166-1#0#19#gene5265","obj":"2788166-1#145#158#diseaseC0023895"}],"text":"Alpha 1-Antitrypsin (alpha 1AT) deficiency is characterized by reduced serum levels of alpha 1AT and a risk for the development of emphysema and liver disease."}

{"project":"UBERON-AE","denotations":[{"id":"PD-UBERON-AE-B_T2","span":{"begin":145,"end":150},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"PD-UBERON-AE-B_T8","span":{"begin":71,"end":76},"obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Alpha 1-Antitrypsin (alpha 1AT) deficiency is characterized by reduced serum levels of alpha 1AT and a risk for the development of emphysema and liver disease."}

{"project":"PubCasesHPO","denotations":[{"id":"AB1","span":{"begin":131,"end":140},"obj":"HP:0002097"}],"text":"Alpha 1-Antitrypsin (alpha 1AT) deficiency is characterized by reduced serum levels of alpha 1AT and a risk for the development of emphysema and liver disease."}

{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T2","span":{"begin":145,"end":150},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"PD-UBERON-AE-B_T8","span":{"begin":71,"end":76},"obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Alpha 1-Antitrypsin (alpha 1AT) deficiency is characterized by reduced serum levels of alpha 1AT and a risk for the development of emphysema and liver disease."}

{"project":"HP-phenotype","denotations":[{"id":"T2","span":{"begin":131,"end":140},"obj":"Phenotype"},{"id":"T3","span":{"begin":145,"end":158},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0002097"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"HP:0001392"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Alpha 1-Antitrypsin (alpha 1AT) deficiency is characterized by reduced serum levels of alpha 1AT and a risk for the development of emphysema and liver disease."}

{"project":"mondo_disease","denotations":[{"id":"T3","span":{"begin":131,"end":140},"obj":"Disease"},{"id":"T4","span":{"begin":145,"end":158},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0004849"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005154"}],"text":"Alpha 1-Antitrypsin (alpha 1AT) deficiency is characterized by reduced serum levels of alpha 1AT and a risk for the development of emphysema and liver disease."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T3","span":{"begin":145,"end":150},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":"Alpha 1-Antitrypsin (alpha 1AT) deficiency is characterized by reduced serum levels of alpha 1AT and a risk for the development of emphysema and liver disease."}

{"project":"Anatomy-MAT","denotations":[{"id":"T3","span":{"begin":145,"end":150},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"mat_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MAT_0000097"}],"text":"Alpha 1-Antitrypsin (alpha 1AT) deficiency is characterized by reduced serum levels of alpha 1AT and a risk for the development of emphysema and liver disease."}